A novel transdermal preparation of morphine and possibility of the clinical application for cancer pain

Drug Delivery System

Volumn 11, Issue 6, 1996, Pages 393-397

  Tsukagoshi, Shigeru ^a   Horikoshi, Noboru ^b   Takahashi, Shunji ^b   Kato, Chiaki ^b   Shimizu, Yoshio ^b   Suminaga, Masashi ^c   Kitajima, Toshiharu ^c   Seki, Toshinobu ^d   Morimoto, Yasunori ^d  

^a CANCER INSTITUTE   (Japan)

^b Cancer Institute Hospital   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d JOSAI UNIVERSITY   (Japan)

Author keywords

amelioration of pain; cancer pain; cancer patients adverse effect; morphine transdermal preparation

Indexed keywords

EID: 85009598249     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.11.393     Document Type: Article

References (5)

1. Coyle N, Adelhardt J, Foley KM, Portenoy RK : Character of terminal illness in the advanced cancer patient : Pain and other symptoms during the last four weeks of life. J. Pain Symptom Manage. 5 : 83-93, 1990.
2. Osborne R, Joel S, Trew D, Slevin M : Morphine and metabolite behavior after different routes of morphine administration : Determination of the importance of the active metabolite morphine-6-gluconide. Clin. Pharinacol. Ther. 47 : 12-19, 1990.
3. Iwamoto K, Kleassen CD : First-pass effect of morphine in rats. J. Pharmacol. Exp. Ther. 200 : 236-244, 1977.
4. Joel S, Osborne R, Slevin M : An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. J. Chromatogr. 430 : 394-399, 1988.
5. Matsuzawa T, Wada Y, Shimoyama M, Nakajima K, Seki T et al. : The effect of different routes of administration of the metabolism of morphine : The disposition of morphine and its metabolites after topical application. Biopharm. Drug Disp. 15 : 665-578, 1994.